Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis

Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis

Objective We investigated the risk of acute and late toxicities of concurrent chemoradiotherapy (CCRT) and radiotherapy alone in patients with nasopharynx carcinoma (NPC). Methods In this meta-analysis, we searched the PubMed, Embase, Cochrane Library, and Web of Science databases for eligible rando...

Full description

Bibliographic Details
Main Authors:	Chun Wang, Fei Wang, Xin Min, Qinfang Zhang, Li-juan Shen, Ying Jiang, Jun Yan
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-07-01
Series:	Journal of International Medical Research
Online Access:	https://doi.org/10.1177/0300060519858031

Similar Items

Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis
by: Ji-Jin Yao, et al.
Published: (2017-03-01)

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
by: He Y, et al.
Published: (2018-06-01)

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma
by: Jing-Feng Zong, et al.
Published: (2021-11-01)

Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update
by: Ting Jin, et al.
Published: (2020-01-01)

Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma
by: Yuxun Ding, et al.
Published: (2021-12-01)

Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients
by: Xiang Li, et al.
Published: (2023-06-01)

A Systematic Review and Meta-Analysis of Studies Comparing Concurrent Chemoradiotherapy With Radiotherapy Alone in the Treatment of Stage II Nasopharyngeal Carcinoma
by: Yao-Can Xu, et al.
Published: (2022-07-01)

Induction chemotherapy followed by radiotherapy concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2020-06-01)

The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis
by: Ji-Jin Yao, et al.
Published: (2018-07-01)

Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2021-03-01)

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Kailin Wang, et al.
Published: (2019-05-01)

Effect of Induction Chemotherapy in Nasopharyngeal Carcinoma: An Updated Meta-Analysis
by: Shan-Shan Yang, et al.
Published: (2021-01-01)

Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma.
by: Hai-yan Chen, et al.
Published: (2013-01-01)

Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
by: Yuanxiu Yin, et al.
Published: (2022-07-01)

Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
by: Weiping Wang, et al.
Published: (2017-08-01)

The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis
by: Bi-Cheng Wang, et al.
Published: (2020-05-01)

Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy.
by: Zhong-Guo Liang, et al.
Published: (2016-01-01)

Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study
by: Jingjin Weng, et al.
Published: (2017-10-01)

Precision radiotherapy for nasopharyngeal carcinoma
by: Zhenyu Zhang, et al.
Published: (2024-03-01)

Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy
by: Fangfang Kong, et al.
Published: (2023-03-01)

A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma.
by: Jianshe Wang, et al.
Published: (2015-01-01)

Nutritional Status and Its Influencing Factors of Nasopharyngeal Carcinoma Patients During Chemoradiotherapy
by: WEI Xueyan, et al.
Published: (2020-07-01)

Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer
by: Vivek Verma, et al.
Published: (2018-05-01)

The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N3 disease
by: Yingying Zhang, et al.
Published: (2017-06-01)

Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2020-01-01)

High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis
by: Xin Sun, et al.
Published: (2020-08-01)

Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
by: Xinmao Song, et al.
Published: (2019-07-01)

Impact of induction chemotherapy with concurrent chemoradiotherapy on nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials
by: Ting-Chieh Huang, et al.
Published: (2022-09-01)

Etiology and management of nasopharyngeal hemorrhage after radiotherapy for nasopharyngeal carcinoma
by: Zhan J, et al.
Published: (2019-03-01)

The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapy.
by: Shiping Yang, et al.
Published: (2015-01-01)

Current Radiotherapy Considerations for Nasopharyngeal Carcinoma
by: Wai Tong Ng, et al.
Published: (2022-11-01)

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Rui Zou, et al.
Published: (2021-02-01)

Role of long non-coding RNA in chemoradiotherapy resistance of nasopharyngeal carcinoma
by: Yang Yang, et al.
Published: (2024-02-01)

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era
by: Shan‐Shan Yang, et al.
Published: (2022-02-01)

Contralateral Lower Neck Sparing Radiotherapy in Stage N1 Nasopharyngeal Carcinoma: Long-Term Survival Outcomes and Late Toxicities
by: Zhuang Sun, et al.
Published: (2021-02-01)

Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma
by: Mengze Wang, et al.
Published: (2024-02-01)

Impairment mechanism of nasal mucosa after radiotherapy for nasopharyngeal carcinoma
by: Caishan Fang, et al.
Published: (2022-12-01)

Effects of Surgery Combined with Chemoradiotherapy on Short- and Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma
by: Weng JJ, et al.
Published: (2020-08-01)

Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy
by: Da-Wei Zhao, et al.
Published: (2022-05-01)

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study
by: Yang Li, et al.
Published: (2017-08-01)